Generalized Anxiety Disorder
Anxiety neurosis; Free-floating anxiety; GAD
Generalized anxiety disorder (GAD) is characterized by an excessive and inappropriate worrying that is persistent and not restricted to particular circumstances. Patients have physical anxiety symptoms (such as tachycardia and tremor) and key psychological symptoms, including restlessness, fatigue, difficulty in concentrating, irritability, and disturbed sleep. The disorder is common and disabling; a recent review of epidemiological studies in Europe suggests a 12-month prevalence of between 1.7 % and 3.75 % (being more common in old age), and the associated functional impairment is similar to that with major depression. However, many of those who might benefit from treatment are not recognized or treated, which is disappointing, as a broad range of evidence-based treatments is available.
Role of Pharmacotherapy
Efficacy in Acute Treatment
Current evidence-based guidelines for the pharmacological management of patients...
- Baldwin DS, Stein DJ, Dolberg OT, Bandelow B (2009) How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database. Hum Psychopharmacol 24:269–275CrossRefPubMedGoogle Scholar
- Bandelow B, Zohar J, Hollander E et al (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 9:248–312CrossRefPubMedGoogle Scholar